Aclarion, Inc. (ACON) News
Follow Aclarion, Inc. (ACON) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
BROOMFIELD, Colo., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intellige
NEWS | Sep 29, 2026, 11:08 AM UTC
L
Aclarion adds University of Arizona College of Medicine—Phoenix as trial site
Aclarion (ACON) adds the University of Arizona College of Medicine—Phoenix as a CLARITY trial site and expects initial internal data and early interim result disclosure in Q4.
EQUITY | Aug 20, 2026, 11:07 AM UTC
L
ACON Files Patent
ACON files patent according to TradeXchange Newsdesk
EQUITY | Jun 24, 2026, 07:56 PM UTC